These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1234487)

  • 1. Which drugs should we be testing for bioavailability.
    Smith RN
    Br J Clin Pharmacol; 1975 Feb; 2(1):5-7. PubMed ID: 1234487
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
    Jaminet F
    J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioavailability and bioequivalence.
    Skelly JP
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):539-45. PubMed ID: 977792
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 6. Biologic availability and therapeutic equivalence.
    Arnold JD; Sicé J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):546-9. PubMed ID: 977793
    [No Abstract]   [Full Text] [Related]  

  • 7. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
    Cabana BE
    Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].
    Golovenko NIa; Borisiuk IIu
    Biomed Khim; 2008; 54(4):392-407. PubMed ID: 18988456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].
    Schnieders B
    Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A history of biopharmaceutics in the Food and Drug Administration 1968-1993.
    Skelly JP
    AAPS J; 2010 Mar; 12(1):44-50. PubMed ID: 19936940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A time to speak out on bioequivalence and therapeutic equivalence.
    Dettelbach HR
    J Clin Pharmacol; 1986; 26(5):307-8. PubMed ID: 2871052
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of drugs (second of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
    [No Abstract]   [Full Text] [Related]  

  • 14. Generic equivalents: issues and concerns.
    Lamy PP
    J Clin Pharmacol; 1986; 26(5):309-16. PubMed ID: 3700686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health and the elderly: new biopharmaceutic considerations.
    Cabana BE
    Health Aff (Millwood); 1983; 2(3):33-8. PubMed ID: 6654313
    [No Abstract]   [Full Text] [Related]  

  • 16. Biowaiver for Immediate and Modified Release Dosage forms Scientific summary of the CSPS workshop.
    Loebenberg R
    J Pharm Pharm Sci; 2020; 23():. PubMed ID: 32877636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical testing of drugs].
    Elis J
    Cesk Zdrav; 1973; 21(3):126-30. PubMed ID: 4580127
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bioavailability and biopharmaceutics].
    Colombo BM; Colombo MM; De Fusco R
    Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980
    [No Abstract]   [Full Text] [Related]  

  • 19. Society testifies on bioavailability, bioequivalence.
    Hayes AH
    Pa Med; 1975 Sep; 78(9):59-60. PubMed ID: 1178207
    [No Abstract]   [Full Text] [Related]  

  • 20. BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements.
    Davit BM; Kanfer I; Tsang YC; Cardot JM
    AAPS J; 2016 May; 18(3):612-8. PubMed ID: 26943914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.